Canlyniadau Chwilio - Peter A Merkel

Mireinio'r Canlyniadau
  1. 1
    Glucagon-like peptide-1: a major regulator of pancreatic beta-cell function

    Glucagon-like peptide-1: a major regulator of pancreatic beta-cell function gan Riccardo Perfetti, Peter A. Merkel

    Cyhoeddwyd 2000
    Cael y testun llawn Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  2. 2
    Thromboembolic disease in vasculitis

    Thromboembolic disease in vasculitis gan Gunnar Tómasson, Paul A. Monach, Peter A. Merkel

    Cyhoeddwyd 2008
    Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  3. 3
    Patient‐reported outcome assessment in vasculitis may provide important data and a unique perspective

    Patient‐reported outcome assessment in vasculitis may provide important data and a unique perspective gan Karen Herlyn, Bernhard Hellmich, Philip Seo, Peter A. Merkel

    Cyhoeddwyd 2010
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  4. 4
    Effects of duration of glucocorticoid therapy on relapse rate in antineutrophil cytoplasmic antibody–associated vasculitis: A meta‐analysis

    Effects of duration of glucocorticoid therapy on relapse rate in antineutrophil cytoplasmic antibody–associated vasculitis: A meta‐analysis gan Michael Walsh, Peter A. Merkel, Alfred Mahr, David Jayne

    Cyhoeddwyd 2010
    Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  5. 5
    The short half-life of glucagon-like peptide-1 in plasma does not reflect its long-lasting beneficial effects

    The short half-life of glucagon-like peptide-1 in plasma does not reflect its long-lasting beneficial effects gan Hongxiang Hui, Loredana Farilla, Peter A. Merkel, Riccardo Perfetti

    Cyhoeddwyd 2002
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  6. 6
    Avacopan for the Treatment of ANCA-Associated Vasculitis

    Avacopan for the Treatment of ANCA-Associated Vasculitis gan David Jayne, Peter A. Merkel, Thomas J. Schall, Pirow Bekker

    Cyhoeddwyd 2021
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  7. 7
    Evaluation of the Safety and Efficacy of Avacopan, a C5a Receptor Inhibitor, in Patients With Antineutrophil Cytoplasmic Antibody–Associated Vasculitis Treated Concomitantly With Rituximab or Cyclophosphamide/Azathioprine: Protocol for a Randomized, Double-Blind, Active-Controlled, Phase 3 Trial

    Evaluation of the Safety and Efficacy of Avacopan, a C5a Receptor Inhibitor, in Patients With Antineutrophil Cytoplasmic Antibody–Associated Vasculitis Treated Concomitantly With R... gan Peter A. Merkel, David Jayne, Chao Wang, Jan Hillson, Pirow Bekker

    Cyhoeddwyd 2020
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  8. 8
    Visual Complications in Patients with Biopsy-proven Giant Cell Arteritis: A Population-based Study

    Visual Complications in Patients with Biopsy-proven Giant Cell Arteritis: A Population-based Study gan Muna Saleh, Carl Turesson, Martin Englund, Peter A. Merkel, Aladdin J Mohammad

    Cyhoeddwyd 2016
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  9. 9
    Rate of Comorbidities in Giant Cell Arteritis: A Population-based Study

    Rate of Comorbidities in Giant Cell Arteritis: A Population-based Study gan Aladdin J Mohammad, Martin Englund, Carl Turesson, Gunnar Tómasson, Peter A. Merkel

    Cyhoeddwyd 2016
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  10. 10
    Global ethnic and geographic differences in the clinical presentations of anti-neutrophil cytoplasm antibody–associated vasculitis

    Global ethnic and geographic differences in the clinical presentations of anti-neutrophil cytoplasm antibody–associated vasculitis gan Fiona Pearce, Anthea Craven, Peter A. Merkel, Raashid Luqmani, Richard A. Watts

    Cyhoeddwyd 2017
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  11. 11
    Pregnancy Outcomes Among Patients With Vasculitis

    Pregnancy Outcomes Among Patients With Vasculitis gan Megan E. B. Clowse, Rachel L. Richeson, Carl F. Pieper, Peter A. Merkel

    Cyhoeddwyd 2013
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  12. 12
    Subacute bacterial endocarditis with positive cytoplasmic antineutrophil cytoplasmic antibodies and anti-proteinase 3 antibodies

    Subacute bacterial endocarditis with positive cytoplasmic antineutrophil cytoplasmic antibodies and anti-proteinase 3 antibodies gan Hyon K. Choi, Peter Lamprecht, John L. Niles, Wolfgang L. Gross, Peter A. Merkel

    Cyhoeddwyd 2000
    Cael y testun llawn Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  13. 13
    Value of ANCA measurements during remission to predict a relapse of ANCA-associated vasculitis--a meta-analysis

    Value of ANCA measurements during remission to predict a relapse of ANCA-associated vasculitis--a meta-analysis gan Gunnar Tómasson, Peter C. Grayson, Alfred Mahr, Michael P. LaValley, Peter A. Merkel

    Cyhoeddwyd 2011
    Cael y testun llawn Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  14. 14
    Health-related quality of life in patients with newly diagnosed antineutrophil cytoplasmic antibody-associated vasculitis

    Health-related quality of life in patients with newly diagnosed antineutrophil cytoplasmic antibody-associated vasculitis gan Michael Walsh, Chetan Mukhtyar, Alfred Mahr, Karen Herlyn, Raashid Luqmani, Peter A. Merkel, David Jayne

    Cyhoeddwyd 2011
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  15. 15
    Risk of Relapse of Antineutrophil Cytoplasmic Antibody–Associated Vasculitis in a Randomized Controlled Trial of Plasma Exchange and Glucocorticoids

    Risk of Relapse of Antineutrophil Cytoplasmic Antibody–Associated Vasculitis in a Randomized Controlled Trial of Plasma Exchange and Glucocorticoids gan Mats Junek, Peter A. Merkel, Eswari Vilayur, Ron Wald, Nader Khalidi, David Jayne, Michael Walsh

    Cyhoeddwyd 2024
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  16. 16
    Comparison of Treatment Response in Idiopathic and Connective Tissue Disease–associated Pulmonary Arterial Hypertension

    Comparison of Treatment Response in Idiopathic and Connective Tissue Disease–associated Pulmonary Arterial Hypertension gan Rennie L. Rhee, Nicole B. Gabler, Sapna Sangani, Amy Praestgaard, Peter A. Merkel, Steven M. Kawut

    Cyhoeddwyd 2015
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  17. 17
    Outcome Measures Used in Clinical Trials for Behçet Syndrome: A Systematic Review

    Outcome Measures Used in Clinical Trials for Behçet Syndrome: A Systematic Review gan Gülen Hatemi, Peter A. Merkel, Vedat Hamuryudan, Maarten Boers, Haner Di̇reskeneli̇, Sibel Z. Aydin, Hasan Yazıcı

    Cyhoeddwyd 2014
    Cael y testun llawn Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  18. 18
    MultiPLIER: A Transfer Learning Framework for Transcriptomics Reveals Systemic Features of Rare Disease

    MultiPLIER: A Transfer Learning Framework for Transcriptomics Reveals Systemic Features of Rare Disease gan Jaclyn Taroni, Peter C. Grayson, Qiwen Hu, Sean Eddy, Matthias Kretzler, Peter A. Merkel, Casey S. Greene

    Cyhoeddwyd 2019
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  19. 19
    Efficacy and safety of avacopan in patients with ANCA-associated vasculitis receiving rituximab in a randomised trial

    Efficacy and safety of avacopan in patients with ANCA-associated vasculitis receiving rituximab in a randomised trial gan Duvuru Geetha, Anisha B. Dua, Huibin Yue, Jason Springer, Carlo Salvarani, David Jayne, Peter A. Merkel

    Cyhoeddwyd 2023
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  20. 20
    Safety of Avacopan for the Treatment of Antineutrophil Cytoplasmic Antibody–Associated Vasculitis: Combined Data From Three Clinical Trials

    Safety of Avacopan for the Treatment of Antineutrophil Cytoplasmic Antibody–Associated Vasculitis: Combined Data From Three Clinical Trials gan Peter A. Merkel, Michael George, Huibin Yue, Tamara Popov, Andreas Kronbichler, Eithne Nic an Ríogh, David Jayne

    Cyhoeddwyd 2025
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:

Offerynnau Chwilio: